Concord Biotech Limited

rs,

1 Symbol: CONCORDBIO To General Manager, Listing Department BSE Limited Phiroze Jeejabhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 543960 Dear Sir/Ma’am, Sub.: Investor’s Presentatio

75.4%

H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY26 Gross Profit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1

80.2%

Q2FY25 Q2FY26 H1FY25 H1FY26 Gross Profit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H

76.3%

Q2FY26 H1FY25 H1FY26 Gross Profit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26

79.1%

6 H1FY25 H1FY26 Gross Profit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25

44.1%

25 H1FY26 Gross Profit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26

35.8%

Y26 Gross Profit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY2

41.4%

oss Profit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY

33.2%

fit Margin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY26 Q2F

30.9%

gin (%) EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2

25.5%

EBIDTA Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H

29.5%

A Margin (%) PAT Margin (%) 75.4% 80.2% 76.3% 79.1% 44.1% 35.8% 41.4% 33.2% 30.9% 25.5% 29.5% 23.7% • Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25 H1FY26 Q2FY25 Q2FY26 H1FY25

Investor Relations Advisor

1

Investor Relations Advisor

Concord Biotech Limited CIN: L24230GJ1984PLC007440 Mr. Lalit Sethi – Chief Financial Officer lalitsethi@concordbiotech.com www.concordbiotech.com Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Sagar Shroff / Mr. Vatsal Shah sagar.shroff@sgapl.net / vatsal.shah@sgapl.net +91 98205 19303 / +91 88796 59884 www.sgapl.net